# Familiarization and Safety Study of PB127 Ultrasound Contrast Agent

> **NCT00594698** · PHASE2,PHASE3 · COMPLETED · sponsor: **Point Biomedical** · enrollment: 150 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** PB127 for injectable suspension

## Key facts

- **NCT ID:** NCT00594698
- **Lead sponsor:** Point Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2003-09
- **Final completion:** 2003-09
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2008-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00594698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00594698, "Familiarization and Safety Study of PB127 Ultrasound Contrast Agent". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00594698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*